Safety and efficacy study of rivaroxaban in patients with long standing persistent atrial fibrillation during ablation

Trial Profile

Safety and efficacy study of rivaroxaban in patients with long standing persistent atrial fibrillation during ablation

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Aug 2015

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Atrial fibrillation
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 28 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top